Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANDELA: CNI-free Everolimus Regimen in Heart Transplant
NCT00862979Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2009
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in heart transplant rejection, sponsored by Novartis. Started Feb 2009; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT00862979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862979.